Ho Louis K, Nodwell Justin R
Department of Biochemistry, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):233-48. doi: 10.1007/s10295-015-1686-6. Epub 2015 Oct 3.
Environmental microbes produce biologically active small molecules that have been mined extensively as antibiotics and a smaller number of drugs that act on eukaryotic cells. It is known that there are additional bioactives to be discovered from this source. While the discovery of new antibiotics is challenged by the frequent discovery of known compounds, we contend that the eukaryote-active compounds may be less saturated. Indeed, despite there being far fewer eukaryotic-active natural products these molecules interact with a far richer diversity of molecular and cellular targets.
环境微生物会产生具有生物活性的小分子,这些小分子已被广泛挖掘用作抗生素以及少数作用于真核细胞的药物。众所周知,从这一来源还能发现更多的生物活性物质。虽然新抗生素的发现因已知化合物的频繁发现而面临挑战,但我们认为作用于真核生物的化合物可能饱和度较低。事实上,尽管作用于真核生物的天然产物数量要少得多,但这些分子与种类丰富得多的分子和细胞靶点相互作用。